Tag: Shockwave IVL
Shockwave Medical announces US launch of intravascular lithotripsy catheter
Today, Shockwave Medical announced the US launch of its Shockwave Javelin peripheral intravascular lithotripsy (IVL) catheter, a platform designed to modify calcium and cross...
Shockwave Medical expands US peripheral IVL portfolio with enhanced catheter
Shockwave Medical, part of Johnson & Johnson MedTech, has announced the full US launch of its Shockwave E8 peripheral intravascular lithotripsy (IVL) catheter, following...
CIRSE begins CALCIO trial enrolment for treatment of CLTI with Shockwave...
The Cardiovascular and Interventional Society of Europe (CIRSE) has announced that patient enrolment for the CALCIO trial has begun. CALCIO started patient enrolment on...
Shockwave L6 catheter expands treatment options for large-vessel cases
NOTE: This video is ONLY available to watch in selected countries and geographies
The benefits of Shockwave Medical’s new Shockwave L6 Peripheral Intravascular Lithotripsy (IVL)...
Shockwave L6 catheter achieves ‘almost pristine’ result in challenging case
NOTE: This video is ONLY available to watch in selected countries and geographies
Experts gathered at the Society for Vascular Surgery’s 2023 Vascular Annual...
Shockwave IVL the “final piece of the puzzle” to safe, effective...
As the new kid on the block, endovascular treatment of the common femoral artery (CFA) just does not have that long-term outcome data yet,”...
Choose the right endograft for your patient with Shockwave IVL
Giacomo Isernia (Perugia, Italy) sits down with Vascular News to discuss the challenges posed by calcium when it comes to endograft delivery. Calcium “limits the ability...
The advantages of an endovascular approach for CFA treatment with Shockwave...
Treatment of common femoral artery (CFA) stenosis, either with an open or endovascular approach, is the subject of much debate, Raphaël Coscas (Paris, France)...
Shockwave IVL can preserve patients’ future options by increasing vessel wall...
Bella Huasen (Preston, UK) talks to Vascular News about some of the difficulties of treating occlusive disease in the femoropopliteal segment and why it is “essential...
